Healthcare
Discover news, funding updates, regulatory changes, and sector insights impacting the health care industry in India.
Healthcare
Bottomline: InvAscent-backed Symbiotec has struggled to break out; will FY25 be different?
Homegrown corticosteroid and hormones API-maker Symbiotec Lifesciences Pvt. Ltd’s revenue and profitability took a hit......
Healthcare
Angels-backed Medyseva set for pre-Series A round
Indore-based telemedicine firm Medyseva Technologies Pvt. Ltd, which is backed by a group of angel investors chaired by ......
Healthcare
Egyptian PE firm Ezdehar strikes second bet in a week
Egyptian mid-market focussed private equity firm Ezdehar, which hit the final close of its latest vehicle in 2022 with ......
Healthcare
How Gulf Islamic Investments' latest healthcare bet is different from its existing portfolio in sector
UAE-based Gulf Islamic Investments (GII), which manages more than $3 billion in private equity, venture capital, and ......
Healthcare
Investcorp signing off from legacy India bet; Bessemer set for dream harvest
Bahrain-based alternative investment firm Investcorp and Silicon Valley venture capital firm Bessemer Venture Partners......
Healthcare
Indian healthtech in a soup as investors turn cautious on elusive profitability, lack of scale
The Indian healthtech sector may be facing a time of reckoning as investment dries up gradually. As the $6.5 ......
Healthcare
Investcorp, Bessemer to make multifold gains as Medi Assist eyes $1.7 bn tag in IPO
Bahrain-based alternative investment firm Investcorp and Silicon Valley venture capital firm Bessemer Venture Partners......
Healthcare
True North presses exit button on one of its single-biggest PE bets
Private equity firm True North, which made several monetisation moves in 2023 while also slashing the target corpus of ......
Healthcare
Bottomline: ChrysCap, SWFs-backed Intas Pharma facing headwinds
Gujarat-based drugmaker Intas Pharmaceuticals Ltd has had a nearly three-decade-long tryst with private equity investors......
Healthcare
Kotak's second special situations PE fund bankrolling big-ticket pharma acquisition
Kotak Alternate Asset Managers (previously Kotak Investment Advisors), the alternative investment arm of Kotak Group, ......









